Evolving trends in pediatric thyroid nodules and cancer management

Area of Science:

• Oncology
• Pediatric Endocrinology
• Genetics

Background:

• Differentiated thyroid cancer (DTC) is the most common pediatric thyroid cancer, with management historically based on adult data.
• Recent scientific and clinical advances, especially in papillary thyroid carcinoma, are reshaping pediatric DTC care.
• Current ultrasound risk stratification systems are being validated for pediatric thyroid nodules.

Purpose of the Study:

• To summarize evolving paradigms and revised guidelines for pediatric DTC diagnosis and management.
• To review evidence supporting updated approaches to surgical intervention and systemic therapy.
• To highlight advances in understanding pediatric DTC biology and targeted treatment strategies.

Main Methods:

• Review of recent scientific literature and clinical studies on pediatric DTC.
• Analysis of observational studies comparing different treatment interventions.
• Evaluation of genomic alterations and their therapeutic implications in pediatric DTC.

Main Results:

• Ultrasound risk stratification systems are now applicable to pediatric patients for biopsy indications.
• Evidence suggests less extensive initial surgical resection may be favorable.
• Targeted therapies, including small-molecule inhibitors for specific gene fusions, show promise for metastatic pediatric DTC.

Conclusions:

• Pediatric DTC management is shifting towards evidence-based, tailored strategies.
• Advances in understanding oncogenic drivers enable targeted systemic therapies for progressive disease.
• Revised guidelines and emerging paradigms offer improved prognosis and quality of life for pediatric DTC patients.